<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Odyssey Group International Inc — News on 6ix</title>
<link>https://6ix.com/company/odyssey-group-international-inc</link>
<description>Latest news and press releases for Odyssey Group International Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 22 Apr 2026 12:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/odyssey-group-international-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835a5cb78dffbe2df10b41f.webp</url>
<title>Odyssey Group International Inc</title>
<link>https://6ix.com/company/odyssey-group-international-inc</link>
</image>
<item>
<title>Odyssey Health, Inc. Secures Exclusive Global Distribution Rights for BreastCheck™ to Drive Recurring Revenue Growth</title>
<link>https://6ix.com/company/odyssey-group-international-inc/news/odyssey-health-inc-secures-exclusive-global-distribution-rights-for-breastchecktm-to-drive-recurring-revenue-growth</link>
<guid isPermaLink="true">https://6ix.com/company/odyssey-group-international-inc/news/odyssey-health-inc-secures-exclusive-global-distribution-rights-for-breastchecktm-to-drive-recurring-revenue-growth</guid>
<pubDate>Wed, 22 Apr 2026 12:00:00 GMT</pubDate>
<description>Odyssey Health, Inc. (OTCQB: ODYY), a medical device company focused on life-saving technologies, today announced the closing of a definitive sub-license agreement granting its wholly-owned subsidiary, Odyssey Medical Devices, Inc., exclusive worldwide marketing and distribution rights for BreastCheck™.</description>
</item>
<item>
<title>Odyssey Health, Inc. Secures Multi-Million-Dollar, Nine-Year Service Contract and Financing Facility for Up to $25 Million</title>
<link>https://6ix.com/company/odyssey-group-international-inc/news/odyssey-health-inc-secures-multi-million-dollar-nine-year-service-contract-and-financing-facility-for-up-to-dollar25-million</link>
<guid isPermaLink="true">https://6ix.com/company/odyssey-group-international-inc/news/odyssey-health-inc-secures-multi-million-dollar-nine-year-service-contract-and-financing-facility-for-up-to-dollar25-million</guid>
<pubDate>Wed, 19 Nov 2025 13:30:00 GMT</pubDate>
<description>Odyssey Health, Inc. Secures Multi-Million-Dollar, Nine-Year Service Contract and Financing Facility for Up to $25 Million.</description>
</item>
<item>
<title>Odyssey Health, Inc., Enters the $26 Billion Breast Cancer Marketplace</title>
<link>https://6ix.com/company/odyssey-group-international-inc/news/odyssey-health-inc-enters-the-dollar26-billion-breast-cancer-marketplace</link>
<guid isPermaLink="true">https://6ix.com/company/odyssey-group-international-inc/news/odyssey-health-inc-enters-the-dollar26-billion-breast-cancer-marketplace</guid>
<pubDate>Thu, 16 Oct 2025 12:30:00 GMT</pubDate>
<description>Odyssey Health, Inc., Enters the $26 Billion Breast Cancer Marketplace.</description>
</item>
<item>
<title>Odyssey Health, Inc. to Advance Development of its Save A Life Choking Rescue Device</title>
<link>https://6ix.com/company/odyssey-group-international-inc/news/odyssey-health-inc-to-advance-development-of-its-save-a-life-choking-rescue-device</link>
<guid isPermaLink="true">https://6ix.com/company/odyssey-group-international-inc/news/odyssey-health-inc-to-advance-development-of-its-save-a-life-choking-rescue-device</guid>
<pubDate>Tue, 26 Aug 2025 12:30:00 GMT</pubDate>
<description>Odyssey Health, Inc. to Advance Development of its Save A Life Choking Rescue Device.</description>
</item>
<item>
<title>Odyssey Health, Inc. Strengthens Balance Sheet with $8.7 Million in Net Equity</title>
<link>https://6ix.com/company/odyssey-group-international-inc/news/odyssey-health-inc-strengthens-balance-sheet-with-dollar87-million-in-net-equity</link>
<guid isPermaLink="true">https://6ix.com/company/odyssey-group-international-inc/news/odyssey-health-inc-strengthens-balance-sheet-with-dollar87-million-in-net-equity</guid>
<pubDate>Wed, 27 Mar 2024 12:33:12 GMT</pubDate>
<description>Odyssey Health, Inc. Strengthens Balance Sheet with $8.7 Million in Net Equity.</description>
</item>
<item>
<title>Odyssey Health Closes Asset Sale of its Neurological Drug Technology Pipeline Including Concussion Drug Candidate with Oragenics, Inc.</title>
<link>https://6ix.com/company/odyssey-group-international-inc/news/odyssey-health-closes-asset-sale-of-its-neurological-drug-technology-pipeline-including-concussion-drug-candidate-with-oragenics-inc</link>
<guid isPermaLink="true">https://6ix.com/company/odyssey-group-international-inc/news/odyssey-health-closes-asset-sale-of-its-neurological-drug-technology-pipeline-including-concussion-drug-candidate-with-oragenics-inc</guid>
<pubDate>Tue, 02 Jan 2024 13:32:44 GMT</pubDate>
<description>Odyssey Health Closes Asset Sale of its Neurological Drug Technology Pipeline Including Concussion Drug Candidate with Oragenics, Inc..</description>
</item>
<item>
<title>Odyssey Health, Inc. Gains Shareholder Approval for Asset Sale with Oragenics, Inc.</title>
<link>https://6ix.com/company/odyssey-group-international-inc/news/odyssey-health-inc-gains-shareholder-approval-for-asset-sale-with-oragenics-inc</link>
<guid isPermaLink="true">https://6ix.com/company/odyssey-group-international-inc/news/odyssey-health-inc-gains-shareholder-approval-for-asset-sale-with-oragenics-inc</guid>
<pubDate>Tue, 12 Dec 2023 13:31:50 GMT</pubDate>
<description>Odyssey Health, Inc. Gains Shareholder Approval for Asset Sale with Oragenics, Inc..</description>
</item>
<item>
<title>Odyssey Health, Inc, Selects Syneos Health to Support Investigational New Drug Application for Treatment of Concussion </title>
<link>https://6ix.com/company/odyssey-group-international-inc/news/odyssey-health-inc-selects-syneos-health-to-support-investigational-new-drug-application-for-treatment-of-concussion</link>
<guid isPermaLink="true">https://6ix.com/company/odyssey-group-international-inc/news/odyssey-health-inc-selects-syneos-health-to-support-investigational-new-drug-application-for-treatment-of-concussion</guid>
<pubDate>Thu, 16 Nov 2023 13:31:52 GMT</pubDate>
<description>Odyssey Health, Inc, Selects Syneos Health to Support Investigational New Drug Application for Treatment of Concussion.</description>
</item>
<item>
<title>Odyssey Health, Inc. to Provide Company Update and Webcast for Shareholders</title>
<link>https://6ix.com/company/odyssey-group-international-inc/news/odyssey-health-inc-to-provide-company-update-and-webcast-for-shareholders</link>
<guid isPermaLink="true">https://6ix.com/company/odyssey-group-international-inc/news/odyssey-health-inc-to-provide-company-update-and-webcast-for-shareholders</guid>
<pubDate>Wed, 15 Nov 2023 17:02:13 GMT</pubDate>
<description>Odyssey Health, Inc. to Provide Company Update and Webcast for Shareholders.</description>
</item>
<item>
<title>Odyssey Health, Inc. Provides Update on Asset Purchase Agreement with Oragenics, Inc.</title>
<link>https://6ix.com/company/odyssey-group-international-inc/news/odyssey-health-inc-provides-update-on-asset-purchase-agreement-with-oragenics-inc</link>
<guid isPermaLink="true">https://6ix.com/company/odyssey-group-international-inc/news/odyssey-health-inc-provides-update-on-asset-purchase-agreement-with-oragenics-inc</guid>
<pubDate>Wed, 18 Oct 2023 12:32:16 GMT</pubDate>
<description>Odyssey Health, Inc. Provides Update on Asset Purchase Agreement with Oragenics, Inc..</description>
</item>
<item>
<title>OTC Markets Group Welcomes New OTCQB Companies – October 9</title>
<link>https://6ix.com/company/odyssey-group-international-inc/news/otc-markets-group-welcomes-new-otcqb-companies-october-9</link>
<guid isPermaLink="true">https://6ix.com/company/odyssey-group-international-inc/news/otc-markets-group-welcomes-new-otcqb-companies-october-9</guid>
<pubDate>Mon, 09 Oct 2023 11:00:00 GMT</pubDate>
<description>OTC Markets Group Welcomes New OTCQB Companies – October 9.</description>
</item>
<item>
<title>Brett Favre Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)</title>
<link>https://6ix.com/company/odyssey-group-international-inc/news/brett-favre-interview-to-air-on-bloomberg-us-on-the-redchip-money-reportr</link>
<guid isPermaLink="true">https://6ix.com/company/odyssey-group-international-inc/news/brett-favre-interview-to-air-on-bloomberg-us-on-the-redchip-money-reportr</guid>
<pubDate>Thu, 14 Jul 2022 12:00:58 GMT</pubDate>
<description>Brett Favre Interview to Air on Bloomberg U.S. on the RedChip Money Report(R).</description>
</item>
<item>
<title>Odyssey Group International Files Patent On Novel Breath-Propelled Nasal Delivery Device</title>
<link>https://6ix.com/company/odyssey-group-international-inc/news/odyssey-group-international-files-patent-on-novel-breath-propelled-nasal-delivery-device</link>
<guid isPermaLink="true">https://6ix.com/company/odyssey-group-international-inc/news/odyssey-group-international-files-patent-on-novel-breath-propelled-nasal-delivery-device</guid>
<pubDate>Tue, 19 Oct 2021 14:04:10 GMT</pubDate>
<description>Odyssey Group International Files Patent On Novel Breath-Propelled Nasal Delivery Device.</description>
</item>
<item>
<title>Odyssey Group International Begins Enrolling Subjects for Phase 1 Clinical Trial to Treat Concussion</title>
<link>https://6ix.com/company/odyssey-group-international-inc/news/odyssey-group-international-begins-enrolling-subjects-for-phase-1-clinical-trial-to-treat-concussion</link>
<guid isPermaLink="true">https://6ix.com/company/odyssey-group-international-inc/news/odyssey-group-international-begins-enrolling-subjects-for-phase-1-clinical-trial-to-treat-concussion</guid>
<pubDate>Wed, 22 Sep 2021 12:44:09 GMT</pubDate>
<description>Odyssey Group International Begins Enrolling Subjects for Phase 1 Clinical Trial to Treat Concussion.</description>
</item>
<item>
<title>Odyssey Group International to Present at the HC Wainwright 23rd Annual Global Investment Conference</title>
<link>https://6ix.com/company/odyssey-group-international-inc/news/odyssey-group-international-to-present-at-the-hc-wainwright-23rd-annual-global-investment-conference</link>
<guid isPermaLink="true">https://6ix.com/company/odyssey-group-international-inc/news/odyssey-group-international-to-present-at-the-hc-wainwright-23rd-annual-global-investment-conference</guid>
<pubDate>Thu, 09 Sep 2021 12:01:43 GMT</pubDate>
<description>Odyssey Group International to Present at the HC Wainwright 23rd Annual Global Investment Conference.</description>
</item>
<item>
<title>Odyssey Group International Approved to Start Human Trial to Treat Concussion </title>
<link>https://6ix.com/company/odyssey-group-international-inc/news/odyssey-group-international-approved-to-start-human-trial-to-treat-concussion</link>
<guid isPermaLink="true">https://6ix.com/company/odyssey-group-international-inc/news/odyssey-group-international-approved-to-start-human-trial-to-treat-concussion</guid>
<pubDate>Wed, 01 Sep 2021 12:31:26 GMT</pubDate>
<description>Odyssey Group International Approved to Start Human Trial to Treat Concussion.</description>
</item>
<item>
<title>Odyssey Group International Completes Final Drug-Device Combination Product in Preparation for Clinical Trial Launch</title>
<link>https://6ix.com/company/odyssey-group-international-inc/news/odyssey-group-international-completes-final-drug-device-combination-product-in-preparation-for-clinical-trial-launch</link>
<guid isPermaLink="true">https://6ix.com/company/odyssey-group-international-inc/news/odyssey-group-international-completes-final-drug-device-combination-product-in-preparation-for-clinical-trial-launch</guid>
<pubDate>Mon, 30 Aug 2021 12:02:12 GMT</pubDate>
<description>Odyssey Group International Completes Final Drug-Device Combination Product in Preparation for Clinical Trial Launch.</description>
</item>
<item>
<title>Odyssey Group International and Super Bowl MVPs Featured on “Banfield” Discussed Novel Concussion Treatment</title>
<link>https://6ix.com/company/odyssey-group-international-inc/news/odyssey-group-international-and-super-bowl-mvps-featured-on-banfield-discussed-novel-concussion-treatment</link>
<guid isPermaLink="true">https://6ix.com/company/odyssey-group-international-inc/news/odyssey-group-international-and-super-bowl-mvps-featured-on-banfield-discussed-novel-concussion-treatment</guid>
<pubDate>Fri, 06 Aug 2021 12:30:41 GMT</pubDate>
<description>Odyssey Group International and Super Bowl MVPs Featured on “Banfield” Discussed Novel Concussion Treatment.</description>
</item>
<item>
<title>Odyssey Group International Completes IND-enabling Studies, Submits Investigator’s Brochure for Phase 1 Clinical Trial</title>
<link>https://6ix.com/company/odyssey-group-international-inc/news/odyssey-group-international-completes-ind-enabling-studies-submits-investigators-brochure-for-phase-1-clinical-trial</link>
<guid isPermaLink="true">https://6ix.com/company/odyssey-group-international-inc/news/odyssey-group-international-completes-ind-enabling-studies-submits-investigators-brochure-for-phase-1-clinical-trial</guid>
<pubDate>Wed, 04 Aug 2021 13:26:09 GMT</pubDate>
<description>Odyssey Group International Completes IND-enabling Studies, Submits Investigator’s Brochure for Phase 1 Clinical Trial.</description>
</item>
<item>
<title>The Odyssey Group International Sports Advisory Board Including Three Super Bowl MVPs will Appear on “Banfield” to Discuss Concussion Treatments</title>
<link>https://6ix.com/company/odyssey-group-international-inc/news/the-odyssey-group-international-sports-advisory-board-including-three-super-bowl-mvps-will-appear-on-banfield-to-discuss-concussion-treatments</link>
<guid isPermaLink="true">https://6ix.com/company/odyssey-group-international-inc/news/the-odyssey-group-international-sports-advisory-board-including-three-super-bowl-mvps-will-appear-on-banfield-to-discuss-concussion-treatments</guid>
<pubDate>Tue, 27 Jul 2021 12:31:09 GMT</pubDate>
<description>The Odyssey Group International Sports Advisory Board Including Three Super Bowl MVPs will Appear on “Banfield” to Discuss Concussion Treatments.</description>
</item>
</channel>
</rss>